| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 41.891 | 27.494 | 38.352 | 42.317 | 35.483 | 54.322 | 51.443 | 8.604 | 0 |
| Total Income - EUR | - | 46.315 | 28.736 | 42.814 | 46.106 | 38.855 | 54.521 | 57.404 | 8.780 | 483 |
| Total Expenses - EUR | - | 19.975 | 18.283 | 17.420 | 19.173 | 12.785 | 13.875 | 16.138 | 18.914 | 11.453 |
| Gross Profit/Loss - EUR | - | 26.340 | 10.453 | 25.394 | 26.933 | 26.070 | 40.647 | 41.266 | -10.134 | -10.970 |
| Net Profit/Loss - EUR | - | 25.413 | 10.035 | 24.966 | 26.472 | 25.554 | 39.209 | 40.257 | -10.230 | -10.970 |
| Employees | - | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Focus Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 408 | 292 | 5.206 | 4.231 | 3.329 | 11.241 | 8.205 | 5.785 | 2.869 |
| Current Assets | - | 26.551 | 35.623 | 53.414 | 65.700 | 78.388 | 102.379 | 132.308 | 7.018 | 222 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 719 | 942 | -71 | 741 | 2.427 | 1.692 | 1.088 | 172 |
| Cash | - | 26.551 | 34.904 | 52.472 | 65.771 | 77.647 | 99.953 | 130.617 | 5.930 | 49 |
| Shareholders Funds | - | 25.457 | 35.061 | 53.729 | 65.962 | 78.298 | 107.790 | 137.173 | 7.978 | -3.037 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.502 | 854 | 4.891 | 3.969 | 3.419 | 5.831 | 3.340 | 4.825 | 6.127 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Focus Clinical Research Srl